Abstract
A clinical trial is monitored for efficacy or safety; the variable of interest is death or a similarly serious event. The probability that one therapy has a greater mortality rate than the other is calculated ad libitum during the trial. Adjustments are made for differing patients'' prognoses and for survival times.

This publication has 2 references indexed in Scilit: